Sanai Health Industry Group Company Limited (HKG:1889)
Hong Kong
· Delayed Price · Currency is HKD 0.335
-0.020 (-5.63%)
At close: Mar 10, 2026
HKG:1889 Revenue
Sanai Health Industry Group Company had revenue of 47.22M CNY in the half year ending June 30, 2025, a decrease of -22.95%. This brings the company's revenue in the last twelve months to 95.71M, up 0.24% year-over-year. In the year 2024, Sanai Health Industry Group Company had annual revenue of 85.22M, down -20.92%.
Revenue (ttm)
95.71M CNY
Revenue Growth
+0.24%
P/S Ratio
0.49
Revenue / Employee
651.09K CNY
Employees
147
Market Cap
51.22M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 85.22M | -22.55M | -20.92% |
| Dec 31, 2023 | 107.77M | -68.16M | -38.74% |
| Dec 31, 2022 | 175.92M | 108.32M | 160.21% |
| Dec 31, 2021 | 67.61M | -53.80M | -44.31% |
| Dec 31, 2020 | 121.40M | 39.55M | 48.32% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Qianhai Health Holdings | 553.58M |
| Kontafarma China Holdings | 891.73M |
| PuraPharm Corporation | 346.76M |
| Joyzyme Group | 28.24M |
| Extrawell Pharmaceutical Holdings | 52.65M |
| Tianda Pharmaceuticals | 310.50M |
| Shenzhen Neptunus Interlong Bio-technique Company | 1.09B |
| Regent Pacific Group | 6.54M |